[1] |
BAIOUMY S A, ESAWY M M, SHABANA M A. Assessment of circulating FCεRIa in chronic spontaneous urticaria patients and its correlation with clinical and immunological variables[J]. Immunobiology, 2018,223(12):807-811.
DOI
URL
|
[2] |
LU T, CHEN Y, GUO Y, et al. Altered gut microbiota diversity and composition in chronic urticaria[J]. Dis Markers, 2019,2019:6417471.
|
[3] |
李琳琳, 杨浩, 王烨. 肠道菌群代谢产物短链脂肪酸与2型糖尿病的关系[J]. 新疆医科大学学报, 2017,40(12):1517-1521.
|
[4] |
TRINH H K, PHAM D L, BAN G Y, et al. Altered systemic adipokines in patients with chronic urticaria[J]. Int Arch Allergy Immunol, 2016,171(2):102-110.
DOI
URL
|
[5] |
ATWA M A, EMARA A S, YOUSSEF N, et al. Serum concentration of IL-17,IL-23 and TNF-α among patients with chronic spontaneous urticaria:association with disease activity and autologous serum skin test[J]. J Eur Acad Dermatol Venereol, 2014,28(4):469-474.
DOI
URL
|
[6] |
周雪峰, 陆其明. 微生态制剂治疗缺血性肠炎的疗效观察[J]. 预防医学, 2017,29(12):1256-1257.
|
[7] |
杨浩, 王烨, 王蟾月, 等. 新疆维吾尔族2型糖尿病人群肠道中Faecalibacterium prausnitzii的定量研究[J]. 中国微生态学杂志, 2017,29(9):1005-1008.
|
[8] |
AMINI-KHOEI H, HAGHANI-SAMANI E, BEIGI M, et al. On the role of corticosterone in behavioral disorders,microbiota composition alteration and neuroimmune response in adult male mice subjected to maternal separation stress[J]. Int Immunopharmacol, 2019,66:242-250.
DOI
URL
|
[9] |
NABIZADEH E, JAZANI N H, BAGHERI M, et al. Association of altered gut microbiota composition with chronic urticaria[J]. Ann Allergy Asthma Immunol, 2017,119(1):48-53.
DOI
URL
|
[10] |
REZAZADEH A, SHAHABI S, BAGHERI M, et al. The protective effect of Lactobacillus and Bifidobacterium as the gut microbiota members against chronic urticaria[J]. Int Immunopharmacol, 2018,59:168-173.
DOI
URL
|
[11] |
WANG D, GUO S, HE H, et al. Gut microbiome and serum metabolome analyses identify unsaturated fatty acids and butanoate metabolism induced by gut microbiota in patients with chronic spontaneous urticaria[J]. Front Cell Infect Microbiol, 2020,10:24.
DOI
URL
|
[12] |
XU J, LIANG R, ZHANG W, et al. Faecalibacterium prausnitzii-derived microbial anti-inflammatory molecule regulates intestinal integrity in diabetes mellitus mice via modulating tight junction protein expression[J]. J Diabetes, 2020,12(3):224-236.
DOI
URL
|
[13] |
BYNDLOSS M X, OLSAN E E, RIVERA-CHÁVEZ F, et al. Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion[J]. Science, 2017,357(6351):570-575.
DOI
URL
|
[14] |
MANRIQUE VERGARA D, GONZÁLEZ SÁNCHEZ M E. Short chain fatty acids(butyric acid) and intestinal diseases[J]. Nutr Hosp, 2017,34(Suppl 4):58-61.
|
[15] |
陈兆桂, 于成功. Faecalibacterium prausnitzii对实验性结肠炎中TLR4/NF-κB信号通路的影响[J]. 胃肠病学, 2016,21(11):644-649.
|
[16] |
NI W W, ZHANG Q M, ZHANG X, et al. Modulation effect of Lactobacillus acidophilus KLDS 1.0738 on gut microbiota and TLR4 expression in β-lactoglobulin-induced allergic mice model[J]. Allergol Immunopathol(Madr), 2020,8(2):149-157.
|
[17] |
SETH R K, KIMONO D, ALHASSON F, et al. Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic metabolic reprogramming in a mouse model of Gulf War Illness[J]. Toxicol Appl Pharmacol, 2018,350:64-77.
DOI
URL
|
[18] |
JI X, ZHANG X, LI H, et al. Nfa34810 facilitates Nocardia farcinica invasion of host cells and stimulates tumor necrosis factor alpha secretion through activation of the NF-κB and mitogen-activated protein kinase pathways via Toll-like receptor 4[J]. Infect Immun, 2020,8(4):e00831-19.
|
[19] |
KRASOVSKA V, DOERING L C. Regulation of IL-6 secretion by astrocytes via TLR4 in the fragile X mouse model[J]. Front Mol Neurosci, 2018,11:272.
DOI
URL
|
[20] |
DE MONTJOYE L, CHOTEAU M, HERMAN A, et al. IL-6 and IL-1β expression is increased in autologous serum skin test of patients with chronic spontaneous urticaria[J]. Allergy, 2019,74(12):2522-2524.
DOI
URL
|
[21] |
SHARMA P, SHARMA P K, CHITKARA A, et al. To evaluate the role and relevance of cytokines IL-17,IL-18,IL-23 and TNF-α and their correlation with disease severity in chronic urticaria[J]. Indian Dermatol Online J, 2020,11(4):594-597.
|
[22] |
SAND F L, THOMSEN S F. Off-label use of TNF-alpha inhibitors in a dermatological university department:retrospective evaluation of 118 patients[J]. Dermatol Ther, 2015,28(3):158-165.
DOI
URL
|
[23] |
KOLKHIR P, ALTRICHTER S, MUNOZ M, et al. New treatments for chronic urticaria[J]. Ann Allergy Asthma Immunol, 2020,124(1):2-12.
DOI
URL
|
[24] |
DEZA G, RICKETTI P A, GIMÉNEZ-ARNAU A M, et al. Emerging biomarkers and therapeutic pipelines for chronic spontaneous urticaria[J]. J Allergy Clin Immunol Pract, 2018,6(4):1108-1117.
DOI
URL
|
[25] |
NETTIS E, LEO E D, PASTORE A, et al. Probiotics and refractory chronic spontaneous urticaria[J]. Ann Allergy Clin Immunol, 2016,48(5):182-187.
|